Glycosylation and the cystic fibrosis transmembrane conductance regulator
<p>Abstract</p> <p>The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan <it>et a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-08-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://respiratory-research.com/content/2/5/276 |
id |
doaj-10df92c80243437e80e4787ced917dae |
---|---|
record_format |
Article |
spelling |
doaj-10df92c80243437e80e4787ced917dae2020-11-25T01:27:25ZengBMCRespiratory Research1465-99212001-08-012527627910.1186/rr69Glycosylation and the cystic fibrosis transmembrane conductance regulatorGlick Mary CatherineScanlin Thomas F<p>Abstract</p> <p>The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan <it>et al</it> in <it>Glycobiology</it>. Using cells that overexpress wild-type (wt)CFTR, the presence of polylactosamine was noted on the fully glycosylated form of CFTR. In the present commentary the results of that work are discussed in relation to the glycosylation phenotype of cystic fibrosis (CF), and the cellular localization and processing of ΔF508 CFTR. The significance of the glycosylation will be known when endogenous CFTR from primary human tissue is examined.</p> http://respiratory-research.com/content/2/5/276ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR)oligosaccharidespolylactosamine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Glick Mary Catherine Scanlin Thomas F |
spellingShingle |
Glick Mary Catherine Scanlin Thomas F Glycosylation and the cystic fibrosis transmembrane conductance regulator Respiratory Research ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) oligosaccharides polylactosamine |
author_facet |
Glick Mary Catherine Scanlin Thomas F |
author_sort |
Glick Mary Catherine |
title |
Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_short |
Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_full |
Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_fullStr |
Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_full_unstemmed |
Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_sort |
glycosylation and the cystic fibrosis transmembrane conductance regulator |
publisher |
BMC |
series |
Respiratory Research |
issn |
1465-9921 |
publishDate |
2001-08-01 |
description |
<p>Abstract</p> <p>The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan <it>et al</it> in <it>Glycobiology</it>. Using cells that overexpress wild-type (wt)CFTR, the presence of polylactosamine was noted on the fully glycosylated form of CFTR. In the present commentary the results of that work are discussed in relation to the glycosylation phenotype of cystic fibrosis (CF), and the cellular localization and processing of ΔF508 CFTR. The significance of the glycosylation will be known when endogenous CFTR from primary human tissue is examined.</p> |
topic |
ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) oligosaccharides polylactosamine |
url |
http://respiratory-research.com/content/2/5/276 |
work_keys_str_mv |
AT glickmarycatherine glycosylationandthecysticfibrosistransmembraneconductanceregulator AT scanlinthomasf glycosylationandthecysticfibrosistransmembraneconductanceregulator |
_version_ |
1725105702514458624 |